Itzhak D. Goldberg
Nessuna posizione attualmente
Profilo
Itzhak D.
Goldberg is the founder of Angion Biomedica Corp.
which was founded in 1998.
He held the titles of Executive Chairman & Chief Scientific Officer from 2018 to 2022.
Dr. Goldberg's former job was as a Professor-Radiation Oncology at Albert Einstein College of Medicine, Inc. Dr. Goldberg received his doctorate degree from Albert Einstein College of Medicine, Inc. in 1976.
Precedenti posizioni note di Itzhak D. Goldberg
| Società | Posizione | Fine |
|---|---|---|
| Albert Einstein College of Medicine, Inc. | Corporate Officer/Principal | - |
| ANGN BIOM | Chief Executive Officer | 01/03/2018 |
Formazione di Itzhak D. Goldberg
| Albert Einstein College of Medicine, Inc. | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 1 |
|---|---|
Angion Biomedica Corp.
 Angion Biomedica Corp. Pharmaceuticals: MajorHealth Technology Angion Biomedica Corp. operates as a biopharmaceutical company. The firm focuses on the discovery and development of novel therapeutic agents to address acute organ injuries and fibrotic diseases. Its product pipeline includes ANG-3777, ANG-3070, ROCK2 Inhibitor and CYP11B2 Inhibitors. The company was founded by Itzhak D. Goldberg on April 6, 1998 and is headquartered in Newton, MA. | Health Technology |
- Borsa valori
- Insiders
- Itzhak D. Goldberg
